{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:01:59Z","timestamp":1773723719545,"version":"3.50.1"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","award":["(GSK study identifier VEO-000308)"],"award-info":[{"award-number":["(GSK study identifier VEO-000308)"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/21645515.2023.2202124","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T08:24:05Z","timestamp":1682583845000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV\/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4054-8682","authenticated-orcid":false,"given":"Marina","family":"George","sequence":"first","affiliation":[{"name":"Hari Group Limited","place":["Greater Manchester, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-4199","authenticated-orcid":false,"given":"Jaime","family":"P\u00e9rez Martin","sequence":"additional","affiliation":[{"name":"Murcia Health Council","place":["Murcia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3342-9730","authenticated-orcid":false,"given":"Mohammad","family":"AbdelGhany","sequence":"additional","affiliation":[{"name":"GSK","place":["Cairo, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-6374","authenticated-orcid":false,"given":"Foteini","family":"Gkalapi","sequence":"additional","affiliation":[{"name":"GSK","place":["Athens, Greece"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-9040","authenticated-orcid":false,"given":"Nicolas","family":"Jamet","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9059-1278","authenticated-orcid":false,"given":"Richelle C.","family":"Kosse","sequence":"additional","affiliation":[{"name":"GSK","place":["Amersfoort, The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-6139","authenticated-orcid":false,"given":"Yara","family":"Ruiz Garc\u00eda","sequence":"additional","affiliation":[{"name":"GSK","place":["Tres Cantos, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-065X","authenticated-orcid":false,"given":"Elisa","family":"Turriani","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-4477","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Berlaimont","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(02)00623-0"},{"key":"e_1_3_7_3_1","unstructured":"World Health Organization. Poliomyelitis. Geneva (CH): WHO; 2022 [accessed 2022 Sept 27]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/poliomyelitis."},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.078"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedhc.2007.09.004"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1044180"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000222413.47344.23"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1362515"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31805d7f17"},{"key":"e_1_3_7_10_1","unstructured":"European Medicines Agency. Infanrix hexa: EPAR - product information. Amsterdam (NL): European Medicines Agency; 2000 [accessed 2022 May 23]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/infanrix-hexa."},{"key":"e_1_3_7_11_1","unstructured":"European Medicines Agency. Hexaxim H-W-2495. Amsterdam (NL): European Medicines Agency; 2012 [accessed 2022 May 23]. https:\/\/www.ema.europa.eu\/en\/hexaxim-h-w-2495."},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.063"},{"key":"e_1_3_7_13_1","unstructured":"European Medicines Agency. Infanrix hexa product characteristics. Amsterdam (NL); 2000 [accessed 2022 May 23]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/infanrix-hexa-epar-product-information_en.pdf."},{"key":"e_1_3_7_14_1","unstructured":"European Medicines Agency. Hexaxim product characteristics. Amsterdam (NL); 2012 [accessed 2022 May 23]. https:\/\/www.ema.europa.eu\/en\/documents\/outside-eu-product-information\/hexaxim-product-information_en.pdf."},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.086"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.12.004"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.040"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000128"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1892493"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.173773"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11113-009-9136-7"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehb.2021.101020"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-016-2868-5"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1698901"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.11606\/s1518-8787.2018052000384"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines5030022"},{"key":"e_1_3_7_27_1","unstructured":"World Health Organization. Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage (data Jordan 2019). Geneva (CH): WHO; 2022 [accessed 2022 Oct 19]. http:\/\/immunizationdata.who.int\/pages\/coverage\/dtp.html?CODE=JOR&ANTIGEN=&YEAR=."},{"key":"e_1_3_7_28_1","unstructured":"European Medicines Agency. Vaxelis. Amsterdam (NL): European Medicines Agency; 2016 [accessed 2022 Aug 22]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vaxelis."},{"key":"e_1_3_7_29_1","unstructured":"United Nations - Department of Economic and Social Affairs -Population Division. World population prospects 2019. Annual population by single age - both sexes. New York (NY): United Nations; 2019 [accessed 2022 May 23]. https:\/\/population.un.org\/wpp\/Download\/Files\/1_Indicators%20Standard\/EXCEL_FILES\/5_Interpolated\/WPP2019_INT_F03_1_POPULATION_BY_AGE_ANNUAL_BOTH_SEXES.xlsx."},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4419"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.023"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.11.090"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.09.027"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2023.2202124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:25:17Z","timestamp":1746815117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2023.2202124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/21645515.2023.2202124"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2023.2202124","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2202124"}}